Lantheus Holdings, Inc. Deferred Income Tax Expense (Benefit)
Lantheus Holdings, Inc. (LNTH) reported Deferred Income Tax Expense (Benefit) of $21.59 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-02-26
- Lantheus Holdings, Inc. deferred income tax expense (benefit) for the quarter ending 2015-12-31 was $184.00K.
- Lantheus Holdings, Inc. deferred income tax expense (benefit) for the quarter ending 2015-09-30 was -$72.00K.
- Lantheus Holdings, Inc. deferred income tax expense (benefit) for the quarter ending 2014-12-31 was -$177.00K.
- Lantheus Holdings, Inc. deferred income tax expense (benefit) for the quarter ending 2014-09-30 was -$10.00K.
- Lantheus Holdings, Inc. deferred income tax expense (benefit) for fiscal 2025 was $21.59M.
- Lantheus Holdings, Inc. deferred income tax expense (benefit) for fiscal 2024 was -$30.03M.
- Lantheus Holdings, Inc. deferred income tax expense (benefit) for fiscal 2023 was -$55.63M.
- Lantheus Holdings, Inc. deferred income tax expense (benefit) for fiscal 2022 was -$48.02M, a 1182.17% decline from fiscal 2021.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2025-12-31 | $21.59M 10-K · filed 2026-02-26 | |||
| 2024-12-31 | -$30.03M 10-K · filed 2026-02-26 | |||
| 2023-12-31 | -$55.63M 10-K · filed 2026-02-26 | |||
| 2022-12-31 | -$48.02M 10-K · filed 2025-02-26 | |||
| 2021-12-31 | $4.44M 10-K · filed 2024-02-22 | |||
| 2020-12-31 | -$1.33M 10-K · filed 2023-02-23 | |||
| 2019-12-31 | $9.72M 10-K · filed 2022-02-24 | |||
| 2018-12-31 | $5.76M 10-K · filed 2021-02-25 | |||
| 2017-12-31 | -$86.95M 10-K · filed 2020-02-25 | |||
| 2016-12-31 | -$17.00K 10-K · filed 2019-02-20 | |||
| 2015-12-31 | $184.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $112.00K derived: sum of 2 quarters · filed 2018-02-26 | $99.00K 10-K · filed 2018-02-26 | |
| 2015-09-30 | -$72.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | -$85.00K 10-Q · filed 2015-11-04 | ||
| 2015-06-30 | -$13.00K 10-Q · filed 2015-08-05 | |||
| 2014-12-31 | -$177.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$187.00K derived: sum of 2 quarters · filed 2017-02-23 | -$207.00K 10-K · filed 2017-02-23 | |
| 2014-09-30 | -$10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | -$30.00K 10-Q · filed 2015-11-04 | ||
| 2014-06-30 | -$20.00K 10-Q · filed 2015-08-05 | |||
| 2013-12-31 | -$272.00K 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |